Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations…
Why AstraZeneca Stock Bumped Higher Today The company is wasting little time figuring out the particulars of a sweeping capital investment program.…
AstraZenecas $2B manufacturing investment in Maryland to create jobs AstraZeneca is investing $2 billion in manufacturing in Maryland that will support 2,600 jobs, state and company officials announced Friday.…
AstraZeneca to invest $2 billion expanding Maryland manufacturing sites By Investing.com AstraZeneca to invest $2 billion expanding Maryland manufacturing sites…
AstraZeneca to invest $2 billion as part of US manufacturing push AstraZeneca said on Friday it will invest $2 billion to expand its manufacturing footprint in Maryland as part of its…
Chutes & Ladders— Former FDA official to lead policy at Hims & Hers; ATA CEO to retire in December Welcome to this weeks Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the…
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…
FTSE 100 hits record high as job market data weakens pound; AstraZeneca shines By Reuters FTSE 100 hits record high as job market data weakens pound; AstraZeneca shines…
Lisata (LSTA) Q3 2025 Earnings Call Transcript Image source: The Motley Fool.DATEThursday, Nov. 6, 2025 at 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Dr. David…
AZN Q3 Earnings Top Estimates, Sales Rise As Most Key Drugs Outperform AstraZeneca posts strong Q3 results. Core earnings and revenues beat estimates as key drugs like Tagrisso, Imfinzi and Farxiga fuel…
AstraZeneca climbs to net all-time high after US deal reassurance AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) posted what analysts called a very solid set of third-quarter results, but the shares barely moved in…
AstraZeneca climbs to new high after US deal reassurance AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) posted what analysts called a very solid set of third-quarter results, where guidance was maintained and the…
Astrazeneca: Starkes Quartal dank Krebsarzneien und gute Aussichten für 2026 CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat ein weiteres überraschend starkes Quartal hinter sich. In den drei Monaten bis…
AstraZeneca beats forecasts in Q3, reaffirms full-year guidance By Investing.com AstraZeneca beats forecasts in Q3, reaffirms full-year guidance…
AstraZeneca grows faster than expected but maintains guidance AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) posted a confident set of third-quarter results, not only beating revenue and core earnings forecasts, but also...…
FTSE 100 Live: Blue-chips slide as Smith & Nephew disappoints, Bank of England holds FTSE 100 falls 20 points to 9,757 Bank of England decision due at midday AstraZeneca beats forecasts but shares little-moved Towering…
AstraZeneca beats third-quarter revenue and profit expectations AstraZeneca beat third-quarter earnings expectations on Thursday, helped by strong sales of key cancer, heart and kidney disease drugs, prompting…
Halozyme (HALO) Q3 2025 Earnings Call Transcript Image source: The Motley Fool.DATEMonday, Nov. 3, 2025 at 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Helen TorleySenior…
AstraZeneca wins shareholder backing for NYSE listing in US pivot AstraZeneca shareholders approved a direct listing of the drugmakers shares on the New York Stock Exchange on Monday, giving it…
AstraZeneca wins shareholder backing for NYSE listing as drugmaker pivots to US AstraZeneca shareholders approved a direct listing of the drugmakers shares on the New York Stock Exchange on Monday, giving it…